woman drawing chemical chain on glass

Pharma Services

NeoGenomics offers lab services for oncology clinical trials

Learn more

NeoGenomics booth display at trade show event

COVID-19

Precision Medicine during this Crisis

NeoGenomics and other organizations in the healthcare community unite to form COVID-19 testing industry consortium.

Click here to view

Latest

Presented:
Source: Webinar

Gastrointestinal Tract Tumor Board

Presented:
Source: Webinar

Gastrointestinal Tract Tumor Board

Image
Pharma blog post icon
Published:
Source: Article

Trends – Epigenetic Biomarkers

In the oncology biomarker field, there are obvious trends in technology and markers as well as…
Presented:
Source: Webinar

Breast Cancer Tumor Board

NeoGenomics is proud to offer our Molecular Tumor Boards covering relevant topics in cancer care.…
Presented:
Source: Webinar

Lung Cancer Tumor Board

NeoGenomics is proud to offer our Molecular Tumor Boards covering relevant topics in cancer care.…

New Tests

Image
IHC icon
Available: May 24, 2021
Methodology: Immunohistochemistry (IHC)

PD-L1 LDT

Programmed cell death ligand 1 (PD-L1) is a transmembrane protein involved in cellular and humoral…
Image
FISH icon
Available: May 24, 2021
Methodology: FISH

Anaplastic Large Cell Lymphoma FISH Panel

Probes: ALK (2p23) | TP63 (3q28) | TBL1XR1/TP63 [inv(3)(q26q28)] | DUSP22-IRF4 (6p25.3) Probes may…
Image
FISH icon
Available: May 24, 2021
Methodology: FISH

TFE3 Rearrangement

Probe(s): TFE3 (Xp11.2) Disease(s): Renal cell carcinoma (RCC), alveolar soft part sarcoma (ASPS)
Image
FISH icon
Available: May 24, 2021
Methodology: FISH

USP6 Rearrangement

Probe(s): USP6 (17p13.2) Disease(s): Nodular fasciitis, aneurysmal bone cysts
Image
Molecular icon
Available: April 23, 2021
Methodology: Molecular

KRAS (G12C) Mutation Analysis for NSCLC

Bi-directional sequencing of exons 2, 3, and 4 of the KRAS (includes G12C mutation) gene including…